EQUASHIELD, a provider of solutions for compounding and administration, announced on Tuesday that it has partnered with Pharmacy Stars, a company that provides a cloud-based platform for pharmacy compliance.
The partnership is aimed at significantly improving safety standards and compliance across healthcare systems nationwide, optimising pharmacy operations with progressive technology and expertise.
EQUASHIELD's Mundus Mini HD leverages its closed system transfer device (CSTD) alongside automation to shield healthcare professionals from hazardous drug exposure, reinforcing comprehensive safety measures. The EQUASHIELD Syringe Unit features a unique dual-needle, air-to-liquid exchange system that maintains pressure equalisation, effectively protecting against the escape of hazardous vapours and aerosols.
The integration of EQUASHIELD's technology with Pharmacy Stars' Compounding360 system offers benefits including enhanced training and compliance that meets USP 797 standards.
NanoVibronix completes pilot phase of UroShield study at University of Michigan
Hologic acquires Gynesonics for USD350m
Inogen secures FDA clearance for SIMEOX 200 Airway Clearance Device
Microtech commences human clinical trial of microsensor platform for heart failure
Defense Diagnostics launches DEFENT ONE All-In-One Fentanyl Detection Device in US
HeartBeam secures FDA clearance for innovative at-home heart monitoring device
Eli Lilly to expand Wisconsin facility
GC Biopharma and Novel Pharma report first patient dosed in multinational trial of GC1130A
Abbott launches first patient procedures with investigational TAVI system
SHL Medical to establish tooling and automation sub-group
Epigenic Therapeutics receives New Zealand approval for EPI-003 clinical trial
GRAIL reports first patient tested with blood-based assay in TROPION-Lung12 Phase 3 study